Overcoming Infrastructure Deficiencies in the Retail Supply Chain

The COVID-19 pandemic has had a direct impact on the retail industry in terms of consumer presence in brick-and-mortar stores, growth in eCommerce, and more, but it’s also highlighted some glaring inefficiencies and shortcomings in the industry’s supply chain.

Notably, retailers lack visibility and data regarding their supply chain and its infrastructure, leaving them largely in the dark and forcing reactive approaches to challenges as opposed to proactive ones.

Further, the industry as a whole has been slow to adopt solutions powered by artificial intelligence and machine learning that could help ease that strain and provide more actionable insights.

To explore where the retail industry needs to go from here in addressing these issues, MarketScale host Stephanie Otey invited Vikas Rajput, Vice President of Customer Success for OpsVeda, to share his expert insights.


OpsVeda is a platform solution offering AI-infused solutions that help enterprises engage in proactive agility, optimization and automation based on the discovery and analysis of key data patterns and more.

The duo dove into optimizing production tracking and downstream impact, assess raw material supply challenges, adapt to shipment delays and route changes, optimize inventory, and more, offering retailers a game plan for forging ahead in a world more connected and demanding than ever before.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!


NRF 2022 Retail's Big Show
What’s in the Shopping Cart for the 2022 National Retail Federation’s Big Show?
January 14, 2022
 In just a few short days, from January 16th through the 18th, the National Retail Federation will launch Retail’s Big Show in the shopping capital of the world, New York City. As retail Read more
Schools Struggle to Reach Their Education Technology Goals. Here’s Why and How To Fix It.
January 14, 2022
As we hit the two-year mark of the COVID-19 pandemic, the education sector continues to struggle in adjusting to virtual and hybrid education at scale. In 2020, McKinsey estimated that, due to COVID Read more
85% of Clinical Drug Trials Face Delays. What's the True Cost?
85% of Clinical Drug Trials Face Delays. What’s the True Cost?
January 14, 2022
  Clinical trials can save lives and provide new ways to treat disease. The industry estimates that 85% of all clinical trials face delays due to patient enrollment. Understanding that challenge Read more